About Desano Pharmaceuticals Private Limited
Data last updated:
Desano Pharmaceuticals Private Limited is a foreign private limited company based in Bengaluru, Karnataka, India, a subsidiary of Desano Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24233KA2012FTC130244. Its GSTIN is 29AAECD6003D1Z2 (Karnataka). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹55 Cr and a paid-up capital of ₹49.69 Cr. It is led by directors Li Jingpeng and Sasikumar Kannaiyan.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 77D KIADB Industrial Area Jigani, Bengaluru, Karnataka, India – 560105.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.05 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹27.63 Lakh (net margin -26.2%) and EBITDA of -₹29.22 Lakh (EBITDA margin -27.7%). Revenue has grown at a compounded annual rate (CAGR) of 185% over five years.
The company has about 163 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Shanghai Desano Chemical Pharmaceuticals. As per MCA filings, the company has open charges of ₹50 Cr on record. The company has 2 deals on record (2 rights issues); the latest was in November 2019. Its 10 peer companies in the Pharma industry (Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Zymeds Pharmaceuticals Private Limited with revenue of ₹1.06 Cr. The company has 27 MSME Form 1 returns on record between 2021 and 2024, listing 1,698 overdue payments to 82 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website desano.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo. 77D KIADB Industrial Area Jigani, Bengaluru, Karnataka, India – 560105
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Desano Pharmaceuticals Private Limited FY 2025 filings available
Desano Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (up 282% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Desano Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 185% over five years, including 282% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Desano Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹29.22 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹27.63 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Desano Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -26.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Desano Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zymeds Pharmaceuticals Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 28.0% | •••• | Mumbai, Maharashtra, India |
| Lilyan Pharmaceuticals Private Limited | ₹1.06 Cr (FY 2024) | •••• | •••• | 1230.0% | •••• | Ulhasnagar, Maharashtra, India |
| Bionomics Lifesciences Private Limited | ₹1.06 Cr (FY 2022) | •••• | •••• | 87.0% | •••• | Ambala Cantt, Haryana, India |
| Novastream Health Care Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Miraj, Maharashtra, India |
| Aerochem Impex Private Limited | ₹1.05 Cr (FY 2019) | •••• | •••• | -21.0% | •••• | Telangana, India |
| Desano Pharmaceuticals Private Limited this company | ₹1.05 Cr (FY 2025) | •••• | •••• | 282.0% | •••• | Bengaluru, Karnataka, India |
| VCS Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Allahabad, Uttar Pradesh, India |
| Harrisons Remedies Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Pune, Maharashtra, India |
| Remedies Pharmaceuticals India Private Limited. | ₹1.05 Cr (FY 2020) | •••• | •••• | -24.0% | •••• | New Delhi, Delhi, India |
| Aktachem Biotech Private Limited | ₹1.05 Cr (FY 2024) | •••• | •••• | -78.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Zafodo Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Palakkad, Kerala, India |
Peers are the five companies nearest above and the five nearest below Desano Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited is audited by RAMAMIRTHAM NATARAJAN & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAMAMIRTHAM NATARAJAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Li Jingpeng | Director | 19 Nov 2012 | 13 Years 10 Months | Current |
| Sasikumar Kannaiyan | Director | 15 Nov 2019 | 6 Years 10 Months | Current |
Ownership and Shareholding of Desano Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Desano Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Apr 2024 | Others | ₹50 Cr | Open |
Total charge records: 1 View all charges
Deals & Funding of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has 2 deals on record (2 rights issues); the latest was in November 2019.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2019 | Rights issue | ₹2.16 Cr | Investors: Desano Limited |
| Feb 2017 | Rights issue | ₹47.49 Cr | Investors: Desano Limited |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has 27 MSME Form 1 returns on record between 2021 and 2024, listing 1,698 overdue payments to 82 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 82)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Leapfrog Engineering Services Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 27 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals operates one associated brand: Shanghai Desano Chemical Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic APIs and FPPs are researched and manufactured. | desano.com |
Employees and EPFO Compliance at Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has a workforce of 163 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233MH2012FTC238017. The current CIN is U24233KA2012FTC130244, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233KA2012FTC130244 | Current |
| U24233MH2012FTC238017 | Previous |
Recent Activity on Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals Private Limited has 9 board changes on record since 2012: 2 appointments and 7 cessations. The latest: Sasikumar Kannaiyan ceased to be Additional Director on 28 Sep 2020.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Desano Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Desano Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECD6003D1Z2 | Karnataka | Active | 13 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Desano Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Desano Pharmaceuticals Private Limited
Desano Pharmaceuticals is an active foreign private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 November 2012 (14+ years old) and is registered under CIN U24233KA2012FTC130244.
Desano Pharmaceuticals reported revenue of ₹1.05 Cr for FY 2025 (up 282% YoY).
Desano Pharmaceuticals has 2 current directors:
- Li Jingpeng - Director
- Sasikumar Kannaiyan - Director
Desano Pharmaceuticals reported a net loss of ₹27.63 Lakh (net margin -26.2%) and EBITDA of -₹29.22 Lakh (EBITDA margin -27.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Desano Pharmaceuticals is 185% over five years. In the latest year (FY 2025) revenue rose 282%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Desano Pharmaceuticals is 29AAECD6003D1Z2, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Desano Pharmaceuticals is U24233KA2012FTC130244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Desano Pharmaceuticals was incorporated on 19 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Desano Pharmaceuticals has 2 deals on record (2 rights issues); the latest was in November 2019.
The peers of Desano Pharmaceuticals by revenue are Zymeds Pharmaceuticals Private Limited, Lilyan Pharmaceuticals Private Limited, Bionomics Lifesciences Private Limited, Novastream Health Care Private Limited, Aerochem Impex Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sasikumar Kannaiyan ceased to be Additional Director on 28 Sep 2020. Li Jinliang ceased to be Director on 17 Jan 2020. Sasikumar Kannaiyan was appointed as Director on 15 Nov 2019. Desano Pharmaceuticals has 9 board changes on record in total.
Desano Pharmaceuticals has 27 MSME Form 1 returns on record between 2021 and 2024, listing 1,698 overdue payments to 82 micro and small suppliers. The latest return was filed on 01 May 2024.